Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator
ID: EP-IDS-16-001 • Type: Posted
Overview
Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 2/17/16 the HHS Office of the Assistant Secretary for Preparedness and Response posted grant opportunity EP-IDS-16-001 for Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator with funding of $250.0 million.
The grant will be issued under grant program 93.360 Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development.
It is expected that one grant will be made
worth between $30.0 million and $30.0 million.
Timing
Posted Date
Feb. 17, 2016, 12:00 a.m. EST
Closing Date
April 15, 2016, 12:00 a.m. EDT Past Due
Closing Date Explanation
Applications must be submitted electronically through www.grants.gov by the application deadline of April 15, 2016 at 11:59PM EDT. ASPR will not accept any applications that are not submitted electronically via www.grants.gov.
Version
9
Archive Date
May 15, 2016
Eligibility
Eligible Applicants
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Small businesses
Public and State controlled institutions of higher education
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
For profit organizations other than small businesses
Small businesses
Public and State controlled institutions of higher education
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
Research institutions and Non-domestic (non-U.S.) entities are eligible.
Application Screening Criteria
Applications that fail to meet the screening criteria described below will not be reviewed and will receive no
further consideration.
1. Applications must be submitted electronically via http://www.grants.gov by April 15, 2016 at 11:59PM
EDT
2. Applicants are required to send a letter of intent to the program office by March 10, 2016 at 11:59PM
EST outlining the project abstract and approximate funding request. Letters of intent should be sent
by email to the attention of Dr. Joseph Larsen at joseph.larsen@hhs.gov. Please see “Attachment F:
Letter of Intent†for additional instructions and a template.
3. A pre-application workshop will be held on March 3, 2016 from 3:00PM – 5:00PM EST in the Hubert H.
Humphrey Building, in the Auditorium, located at 200 Independence Ave SW, Washington, DC 20201
RSVP to this meeting by emailing, Dr. Joseph Larsen at joseph.larsen@hhs.gov, Subject Line: “RSVP for
Accelerator Pre-Application Workshop†by February 29, 2016 at 5:00 PM EST. Please include Names,
Titles, Organizations, Email, Phone and country of citizenship for each member on your team that will
attend.
4. A Technical Assistance Conference Call will be held for only parties that have submitted “Letters of
Intent†on March 18, 2016 at 11:00AM EST. This meeting is designed to address any questions
associated with an application process. BARDA will address any clarifying questions submitted with the
“Letter of intent.†A conference call number will be provided prior to the meeting to only parties that
have submitted “letters of Intentâ€
Award Sizing
Ceiling
$30,000,000
Floor
$30,000,000
Estimated Program Funding
$250,000,000
Estimated Number of Grants
1
Contacts
Contact
Assistant Secretary for Preparedness and Response
Contact Email
Email Description
Grants.gov Customer Support
Additional Information
Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator
Additional Information Site